Shengda Cao

440 total citations
30 papers, 302 citations indexed

About

Shengda Cao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shengda Cao has authored 30 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Shengda Cao's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and Hearing, Cochlea, Tinnitus, Genetics (5 papers). Shengda Cao is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and Hearing, Cochlea, Tinnitus, Genetics (5 papers). Shengda Cao collaborates with scholars based in China, United States and Bangladesh. Shengda Cao's co-authors include Dongmin Wei, Xinliang Pan, Guojun Li, Dapeng Lei, Dapeng Lei, Wenming Li, Wenming Li, Dayu Liu, Jianing Xu and Jieyu Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Shengda Cao

27 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengda Cao China 12 229 179 46 42 31 30 302
Zeng-Hong Li Hong Kong 13 226 1.0× 196 1.1× 53 1.2× 28 0.7× 37 1.2× 13 341
Wanwei Wang China 9 158 0.7× 122 0.7× 54 1.2× 44 1.0× 61 2.0× 15 249
Renya Zhang China 11 162 0.7× 69 0.4× 92 2.0× 84 2.0× 36 1.2× 21 290
Xiaping Wang China 9 164 0.7× 183 1.0× 102 2.2× 59 1.4× 46 1.5× 20 330
Nir Dromi Israel 6 229 1.0× 210 1.2× 62 1.3× 31 0.7× 13 0.4× 6 324
Zhuming Lu China 8 163 0.7× 128 0.7× 59 1.3× 54 1.3× 20 0.6× 13 261
Ai-Jun Zhou China 4 170 0.7× 138 0.8× 73 1.6× 56 1.3× 63 2.0× 5 290
Qian Fei China 10 171 0.7× 151 0.8× 48 1.0× 48 1.1× 26 0.8× 19 264
Ruping Zhao China 10 121 0.5× 96 0.5× 89 1.9× 88 2.1× 27 0.9× 26 261

Countries citing papers authored by Shengda Cao

Since Specialization
Citations

This map shows the geographic impact of Shengda Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengda Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengda Cao more than expected).

Fields of papers citing papers by Shengda Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengda Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengda Cao. The network helps show where Shengda Cao may publish in the future.

Co-authorship network of co-authors of Shengda Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Shengda Cao. A scholar is included among the top collaborators of Shengda Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengda Cao. Shengda Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yunhao, Li Zhang, Shengda Cao, et al.. (2025). Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis. Advanced Science. 12(29). e2405850–e2405850. 1 indexed citations
2.
Hong, Guodong, Ming Xia, Peipei Li, et al.. (2025). mRNA metabolism regulator human antigen R (HuR) regulates age-related hearing loss in aged mice. Nature Aging. 5(5). 848–867.
3.
Wang, Yin, Zinan Li, Xiaorong Sun, et al.. (2025). CircTP53 /USP10/p53 signaling Axis as a Novel Regulator of Progression and Prognosis of Head and Neck Squamous Cell Carcinoma. Advanced Science. 12(30). e14961–e14961.
4.
Guan, Rui, Ce Li, Jingao Li, et al.. (2025). MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway. Journal of Experimental & Clinical Cancer Research. 44(1). 221–221. 1 indexed citations
5.
Zhang, Xiaohan, Ziyi Liu, Xiaoxu Zhao, et al.. (2025). GSDMD-mediated mitochondrial dysfunction in marginal cells: A potential driver of inflammation and stria vascularis damage in CIHL. Proceedings of the National Academy of Sciences. 122(11). e2415805122–e2415805122. 3 indexed citations
6.
Zhao, Xiaoxu, Tian Shen, Shengda Cao, et al.. (2025). Presbycusis: Pathology, Signal Pathways, and Therapeutic Strategy. Advanced Science. 12(29). e2410413–e2410413. 2 indexed citations
8.
Guan, Rui, et al.. (2024). Single-cell transcriptomic landscape and the microenvironment of normal adjacent tissues in hypopharyngeal carcinoma. BMC Genomics. 25(1). 489–489. 1 indexed citations
9.
Xu, Chenyang, Rui Guan, Shengda Cao, et al.. (2024). Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma. International Immunopharmacology. 142(Pt B). 113243–113243. 3 indexed citations
10.
Zhao, Yunpeng, et al.. (2023). Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry. 85. 117242–117242. 7 indexed citations
11.
Fu, Xiaolong, Ling Lü, Ziyi Liu, et al.. (2023). Peroxisome Deficiency in Cochlear Hair Cells Causes Hearing Loss by Deregulating BK Channels. Advanced Science. 10(20). e2300402–e2300402. 8 indexed citations
15.
Li, Wenming, et al.. (2021). A novel surgical approach for hypopharyngeal carcinoma resection via the paraglottic space. BMC Surgery. 21(1). 230–230. 2 indexed citations
16.
Li, Wenming, Dongmin Wei, Shengda Cao, et al.. (2020). Discovery and Validation of a CT‐Based Radiomic Signature for Preoperative Prediction of Early Recurrence in Hypopharyngeal Carcinoma. BioMed Research International. 2020(1). 4340521–4340521. 9 indexed citations
17.
Xu, Jianing, Neil D. Gross, Yuanwei Zang, et al.. (2019). Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma. Molecular Diagnosis & Therapy. 23(3). 407–417. 5 indexed citations
18.
Liu, Xuejun, Zhonghua Zhang, Zuping Zhang, et al.. (2017). E26 Transformation-Specific Transcription Factor ETS2 as an Oncogene Promotes the Progression of Hypopharyngeal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 32(9). 327–334. 12 indexed citations
19.
Liu, Dayu, Shengda Cao, Dongmin Wei, et al.. (2017). Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Molecular Cancer. 16(1). 68–68. 56 indexed citations
20.
Yan, Yan, Dongmin Wei, Wenming Li, et al.. (2017). Surgical management of primary parapharyngeal space tumors in 103 patients at a single institution. Acta Oto-Laryngologica. 138(1). 85–89. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026